NCT01878526View on ClinicalTrials.gov

Gastroesophageal Reflux Treatment in Scleroderma

PHASE3CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

June 30, 2013

Primary Completion Date

August 31, 2015

Study Completion Date

January 31, 2016

Conditions
Gastroesophageal Reflux DiseaseSystemic SclerosisScleroderma
Interventions
DRUG

Alginic acid

Algycon 1 tab chew tid after meal

DRUG

placebo (for domperidone)

placebo (for domperidone) 1 tab oral tid before meal

DRUG

Domperidone

domperidone (10 mg) 1 tab oral tid before meal

DRUG

placebo (of alginic acid)

placebo (for alginic acid) 1 tab chew tid after meal

Trial Locations (1)

40002

123 Department of Medicine, Faculty of Medicine, Khon Kaen University, Khon Kaen

All Listed Sponsors
lead

Khon Kaen University

OTHER

NCT01878526 - Gastroesophageal Reflux Treatment in Scleroderma | Biotech Hunter | Biotech Hunter